List view / Grid view

Venous thromboembolism (VTE)



Atrial fibrillation market will peak at $11.8 billion in 2022

2 August 2016 | By GlobalData

The atrial fibrillation market will expand from approximately $8 billion in 2015 to hit its peak of $11.8 billion in 2022, after which the impact of patent expiries will see the market value fall rapidly to $4.9 billion by 2025, according to research and consulting firm GlobalData...


Servier Canada to market edoxaban in Canada

27 June 2016 | By Victoria White, Digital Content Producer

Edoxaban is an oral anticoagulant that specifically inhibits factor Xa, which is an important factor in the coagulation system that leads to blood clotting...